SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 27 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 216,077,000 | $801,152,000 | 6.66% |
| WOLVERINE ASSET MANAGEMENT LLC | 38,036,000 | $141,627,000 | 2.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,200,000 | $78,718,000 | 1.09% |
| Kohlberg Kravis Roberts & Co. L.P. | 6,500,000 | $24,144,000 | 0.25% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $11,135,000 | 0.18% |
| Visium Asset Management, LP | 2,000,000 | $7,417,000 | 0.11% |
| Citadel Advisors | 21,363,000 | $79,364,000 | 0.08% |
| CITIGROUP INC | 10,369,000 | $38,501,000 | 0.04% |
| FRANKLIN RESOURCES INC | 12,000,000 | $44,618,000 | 0.02% |
| WELLS FARGO & COMPANY/MN | 11,498,000 | $42,630,000 | 0.01% |